Ana sayfa » Hepsi » Hisse Tahminleri » Cellectar Biosciences Inc. Common Stock Tahmin

Cellectar Biosciences Inc. Common Stock Tahmin: Yarın, Hafta, Ay, 5 Yıllar

Güncellendi: April 22 · 2026 at 07:03 UTC

From

▼ -3.73%Market Cap $12.04M · Technical analysis Bearish · Focus area Price + volatility

Tahmin Özeti

Zaman aralığı	Tahmini Fiyat	Geçmiş	Tarihsel	İç yüzü
Yarın	$2.88 ▲ +1.33%	Dün	$2.82 ▼ -0.56%	Tomorrow's Cellectar Biosciences Inc. Common Stock (CLRB) setup is anchored to $2.84 and targets $2.88 (+1.33%). The near-term read is upside; watch $2.93 / $2.75 because daily realized volatility is about 6.84%.
Tomorrow's Cellectar Biosciences Inc. Common Stock (CLRB) setup is anchored to $2.84 and targets $2.88 (+1.33%). The near-term read is upside; watch $2.93 / $2.75 because daily realized volatility is about 6.84%.
Hafta	$2.96 ▲ +4.12%	Geçen Hafta	$2.79 ▼ -1.73%	The 7-day Cellectar Biosciences Inc. Common Stock model moves from $2.79 to $2.96 (+4.12%). It gives upside momentum context for this stock, so breaks around $2.93 / $2.75 matter more than a single tick.
The 7-day Cellectar Biosciences Inc. Common Stock model moves from $2.79 to $2.96 (+4.12%). It gives upside momentum context for this stock, so breaks around $2.93 / $2.75 matter more than a single tick.
Ay	$3.09 ▲ +8.79%	Geçen Ay	$2.74 ▼ -3.69%	The 1-month Cellectar Biosciences Inc. Common Stock target is $3.09 (+8.79%), compared with the live reference near $2.84. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Cellectar Biosciences Inc. Common Stock target is $3.09 (+8.79%), compared with the live reference near $2.84. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Yıl	$3.29 ▲ +15.77%	Geçen Yıl	$2.65 ▼ -6.62%	The 1-year Cellectar Biosciences Inc. Common Stock scenario points to $3.29 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Cellectar Biosciences Inc. Common Stock scenario points to $3.29 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Yıllar	$3.75 ▲ +32.14%	5 Yıllar Önce	$2.46 ▼ -13.50%	The 5-year Cellectar Biosciences Inc. Common Stock view is $3.75 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Cellectar Biosciences Inc. Common Stock view is $3.75 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Yarın$2.88▲ +1.33%

Dün$2.82▼ -0.56%

Tomorrow's Cellectar Biosciences Inc. Common Stock (CLRB) setup is anchored to $2.84 and targets $2.88 (+1.33%). The near-term read is upside; watch $2.93 / $2.75 because daily realized volatility is about 6.84%.

Hafta$2.96▲ +4.12%

Geçen Hafta$2.79▼ -1.73%

The 7-day Cellectar Biosciences Inc. Common Stock model moves from $2.79 to $2.96 (+4.12%). It gives upside momentum context for this stock, so breaks around $2.93 / $2.75 matter more than a single tick.

Ay$3.09▲ +8.79%

Geçen Ay$2.74▼ -3.69%

The 1-month Cellectar Biosciences Inc. Common Stock target is $3.09 (+8.79%), compared with the live reference near $2.84. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

Yıl$3.29▲ +15.77%

Geçen Yıl$2.65▼ -6.62%

The 1-year Cellectar Biosciences Inc. Common Stock scenario points to $3.29 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5 Yıllar$3.75▲ +32.14%

5 Yıllar Önce$2.46▼ -13.50%

The 5-year Cellectar Biosciences Inc. Common Stock view is $3.75 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Fiyat Tablosu

TarihselTahmin etmekYükselişdüşüş eğilimi

Teknik Analiz

Neutral

Yükseliş

Doğal

düşüş eğilimi

Temel Göstergeler

Gösterge	Değer	Sinyal
Price	$2.84	Mid
Daily Change	-3.73%	Below
Volatility Cap	20.0%	Mid
Confidence	65%	Above
Data Source	nasdaq-screener	Mid

Geçmiş Veriler

Current$2.84

Daily Change-3.73%

Market Cap$12.04M

Sourcenasdaq-screener

Current	$2.84	Daily Change	-3.73%
Market Cap	$12.04M	Source	nasdaq-screener

Destek ve Direnç Seviyeleri

$2.75Destek 1

$2.84Mevcut

$2.93Rezistans 1

Support and resistance are estimated from the trusted current price until deeper historical data is available.

Fiyat Aşamaları

Anahtar seviyeler ve tarihsel bağlam

Current$2.84Live reference price

Used as the anchor for generated forecast calculations.

Next Month$3.09Model projection+8.79%

Directional scenario based on capped drift.

Tahmin Doğruluğu

Modelimizin performansı nasıl?

65%

Yönlü

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

Algoritmamız, en son fiyat hareketi, oynaklık rejimi ve gösterge sinyalleri kullanılarak haftalık olarak yeniden kalibre edilir. Doğruluk zaman dilimine göre değişir; kısa vadeli momentum, uzun vadeli tahminlerden daha güvenilirdir.

Short term

65%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

Yatırım Senaryoları

Bugün $1,000'yu CLRB'ya yatırırsanız

Bullish Scenario

$2.98

+5.00% from current

Hedef Fiyat$2.98

SenaryoUpside momentum

Olasılık57%

Base Scenario

$3.09

+8.79%

Hedef Fiyat$3.09

SenaryoCapped drift

Olasılık65%

Bearish Scenario

$2.70

-5.00% from current

Hedef Fiyat$2.70

SenaryoVolatility drawdown

Olasılık35%

Temel: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Tahmin Faktörleri

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bullish · 69/100

24H drift+1.33%

7D drift+4.12%

30D drift+8.79%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-On Tentative · 66/100

1M outlook+8.79%

1Y outlook+15.77%

5Y outlook+32.14%

Sıkça Sorulan Sorular

Q What is the Cellectar Biosciences Inc. Common Stock (CLRB) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Cellectar Biosciences Inc. Common Stock is projected near $2.88 versus the current reference around $2.84. That implies a modeled move of +1.33% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for CLRB?

The weekly Cellectar Biosciences Inc. Common Stock model points to $2.96, which maps to an expected drift of +4.12% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the Cellectar Biosciences Inc. Common Stock 1-month and 1-year targets?

The Cellectar Biosciences Inc. Common Stock 1-month target is $3.09 (+8.79%), while the 1-year target is $3.29 (+15.77%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the Cellectar Biosciences Inc. Common Stock 5-year scenario differ from short-term rows?

The Cellectar Biosciences Inc. Common Stock long-horizon scenario sits near $3.75 with a modeled change of +32.14%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are CLRB support and resistance zones right now?

For Cellectar Biosciences Inc. Common Stock, nearest resistance is around $2.75, while nearest support is around $2.93. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the Cellectar Biosciences Inc. Common Stock market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.